Rheum Advisor on Air

In this episode, we’re highlighting the importance of recognizing and discussing women’s health – from premenstruation through menstruation and pregnancy and menopausal transition – in rheumatology.

In this episode, we get further insight into the current state of biosimilars development and adoption in the United States vs other countries, interchangeability among adult and pediatric patients with rheumatologic conditions, nonmedical switching to biosimilars, and an overview of its potential cost benefits for the US healthcare system.

In part 2 of this series, we’re getting perspectives from an allopathic and an osteopathic physician specializing in rheumatology on the evolution of telemedicine and what the future may look like for the management of rheumatologic conditions.

Telemedicine in rheumatology, or telerheumatology, may be the future of diagnosis and treatment in rheumatology. In this 2-part episode series, we’re delving deeper into the world of telerheumatology and asking, “Will this be the new normal?”